StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by MarketMoneyon Mar 23, 2021 6:42am

204 Views

Post# 32856413

For the first time since 2015

In the montly chart, the shareprice started trading completely above the EMA(30) on February 2021.

This is a very very good sign of a mature stock that as done a good consolidation prior to a weekly stage 2!

Samething happen to GME, Gamestock for the first time since 2016 the shareprice started trading completely above the EMA(30) in February 2021 :-)

You can't compare both for the fundamentals but you can compare the monthly consolidation, the difference is GME started the weekly stage 2 last year ;-)

Have another exciting day!